3Simon T,Opelz G,Wiesel M. Serial peripheral blood perforin and granzyme B gene expression measurements for prediction of acute rejection in kidney graft recipients[J].American Journal of Transplantation,2003,(09):1121-1127.
4García-Roca P,Vargas YA,Fuentes Y. Serum soluble interleukin 2 receptor (sIL-2R) as a marker of acute rejection in renal transplant children[J].Pediatric Transplantation,2012,(03):274-279.
5Everly MJ,Rebellato LM,Ozawa M. Beyond histology:lowering human leukocyte antigen antibody to improve renal allograft survival in acute rejection[J].Transplantation,2010,(08):962-967.
6Shin GT,Kim SJ,Lee TS. Gene expression of perforin by peripheral blood lymphocytes as a marker of acute rejection[J].NEPHRON CLINICAL PRACTICE,2005,(03):c63-c70.
7Karczewski M,Karczewski J,Poniedzialek B. Distinct cytokine patterns in different states of kidney allograft function[J].Transplantation Proceedings,2009,(10):4147-4149.doi:10.1016/j.transproceed.2009.08.067.
8Daniel V,Sadeghi M,Wang H. CD4+CD25+Foxp3+IFN-γ+ human induced T regulatory cells are induced by interferon-γ and suppress alloresponses nonspecifically[J].Human Immunology,2011,(09):699-707.
9Nocera A,Tagliamacco A,Ferrante A. Cytotoxic molecule mRNA expression in chronically rejected human kidney allografts[J].Transplantation Proceedings,2005,(06):2476-2478.
10van de Wetering J,Koumoutsakos P,Peeters A. Discontinuation of calcineurin inhibitors treatment allows the development of FOXP3+ regulatoryT-cells in patients after kidney transplantation[J].Clinical Transplantation,2011,(01):40-46.
5Refaie A,Sobh M,Moustafa F,et al.Living-related-donor kidney transplantation outcome in recipients with primary focal-segmental glomerulosclerosis.Am J Nephrol.1999; 19(1):55-59.
6Alfani D,Pretagostini R,Rossi M,et al.Living unrelated kidney transplantation:a 12-year single center experience.Transplant Proc.1997;29(1-2):191-194.
7Chkhotua AB,Klein T,Shabtai EL,et al.Kidney transplantation from living donors:comparison of results between related and unrelated donor transplants under new immunosuppressive protocols.Isr Med Assoc J.2003;5(9):622-625.
8Ramcharan T,Matas AJ.Long-term (20-37 years) follow-up of living kidney donors.Am J Transplant.2002;2(10):959-964.
9Ingela F,Gilbert TT.Long-term risks after living kidney donation.In:Robert SG,Joans W,eds.Living donor kidney transplantation.UK:Taylor Francis.2005.
5Chang GC,Wu CL,Pan SH,et al. The diagnosis of pneumonia in renal transplant recipients using invasive and noninvasive proce- dures[J].Chest, 2004,125 : 541-547.
6Kupeli E,Ulubay G,Colak T,et al. Pulmonary complications in re- nal recipients after transplantation[J]. Transplant Proc, 2011,43 (2) :551-553.
7De Keyzer K,Van Laecke S,Peeters P,et al. Human cytomegalovirus and kidney transplantation:a clinician, supdate[J]. Am J Kidney Dis,2011,58(1) : 118-126.
8Waiser J, Sehotsehel R, Budde K, et al. Reactivation of tuberculo- sis after conversion from azathioprine to mycophenolate mofetill6 years renal transplantation[J]. Am J Kidney Dis,2000,35(3):E12.
9Matuck T,Brasil P,Alvarenga M,et al. Tuberculosis in renal trans- plants in Rio De Janeiro[J]. Transplant Proc,2004,36 (4):905- 906.
10Hoyo I,Linares L,Cervera C,et al.Epidemiology of Pneumonia in Kidney Transplantation[J]. Transplantation Proceedings,2010,42 (8) :2938-2940.
